More about

Hepatitis B Virus

News
June 28, 2021
1 min read
Save

Tenofovir safe, effective in treating pediatric hepatitis B

Long-term tenofovir treatment in pediatric patients with chronic hepatitis B was well tolerated and correlated with a high rate of viral suppression, according to a study presented at the International Liver Congress.

News
June 26, 2021
1 min read
Save

Research supports continuation of VIR-2218 development for hepatitis B

Research supports continuation of VIR-2218 development for hepatitis B

VIR-2218, an investigational small interfering ribonucleic acid therapeutic, was well tolerated in patients for the treatment of chronic hepatitis B virus, according to research presented at the International Liver Congress.

News
June 25, 2021
2 min read
Save

Hepatic arterial infusion chemotherapy plus sintilimab shows promise for advanced liver cancer

Hepatic arterial infusion chemotherapy plus sintilimab shows promise for advanced liver cancer

Treatment with hepatic arterial infusion chemotherapy in combination with sintilimab allowed for surgical resection and produced survival rates similar to lesser advanced hepatocellular carcinoma, according to a presenter at The International Liver Congress.

News
June 23, 2021
1 min read
Save

Tenofovir reduces COVID-19 severity among patients with chronic hepatitis B

Tenofovir reduced the severity of COVID-19 infection among patients with chronic hepatitis B, according to a presentation at The Digital International Liver Congress.

News
May 18, 2021
1 min read
Save

9 stories for Hepatitis Awareness Month

9 stories for Hepatitis Awareness Month

May is Hepatitis Awareness Month in the United States, and May 19 is Hepatitis Testing Day.

News
May 13, 2021
2 min read
Save

One-time universal screening for hepatitis B could save 23K lives, nearly $600 million

One-time universal screening for hepatitis B could save 23K lives, nearly $600 million

A one-time, universal screening for chronic hepatitis B infection could prevent 23,000 additional deaths from chronic HBV-related liver disease and save almost $600 million, according to a study in Clinical Infectious Diseases.

News
May 01, 2021
1 min read
Save

First patient dosed in a phase 2 combined therapy trial for chronic HBV

Brii Biosciences, Vir Biotechnology and VBI Vaccines announced the first patient dosed in a phase 2 trial evaluating combination therapy for the treatment of patients with chronic hepatitis B infection, according to a press release.

News
March 16, 2021
1 min read
Save

Patients with NASH cirrhosis have poorer prognosis than those with HBV

Patients with NASH cirrhosis have poorer prognosis than those with HBV

Patients with decompensated cirrhosis due to non-alcoholic steatohepatitis had worse outcomes and more complications than patients with hepatitis B virus, according to study results.

News
December 15, 2020
7 min read
Save

USPSTF publishes HBV recommendation amid declines in screening, vaccination

USPSTF publishes HBV recommendation amid declines in screening, vaccination

The United States Preventive Services Task Force recently published a new statement strengthening its 2014 recommendation to screen for hepatitis B virus in adolescents and adults who are at an increased risk for infection.

News
November 23, 2020
1 min read
Save

Global HBV mortality burden remains high

Despite a global initiative to reduce hepatitis B mortality, few of the countries with the highest burden are on track to meet elimination targets, according to research presented at the Liver Meeting Digital Experience.

View more